NSE › Healthcare

Zydus Lifesciences Limited (ZYDUSLIFE)

NSE · Healthcare · Drug Manufacturers - Specialty & Generic

₹1,121.00-0.51%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
₹7,587 cr
Revenue YoY
+16.2%
Net profit
₹1,272 cr
Profit YoY
+8.7%
EPS
₹15.84
EPS estimate
₹9.30
Net margin
16.8%

EPS came in at 15.84 against a street estimate of 9.30 — a beat of 70.3%.

Key statistics

Market cap
₹1.12 lakh cr
P/E
22.4
Forward P/E
14.9
P/B
4.15
Book value
₹269.43
EPS (TTM)
₹50.14
Dividend yield
0.09%
52-week high
₹1,180.43
52-week low
₹834.75
50-day MA
₹1,109.42
200-day MA
₹967.30
Beta
0.37

Analyst view

with an average price target of ₹1,093.73.

Shareholding

Promoters
75.19%
Institutions
15.04%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Zydus Lifesciences Limited — free to start.

Google PlayApp Store

Other Healthcare companies

Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedApollo Hospitals Enterprise LimitedCipla LimitedLupin LimitedMax Healthcare Institute LimitedMankind Pharma LtdLaurus Labs LimitedLenskart Solutions LtdDr. Reddy's Laboratories LimitedAurobindo Pharma Limited

Data updated 2026-08-05.